title: [Results of a multicenter, phase-II clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy].
authors.forename: A M
authors.initials: AM
authors.lastname: Garin
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: M B
authors.initials: MB
authors.lastname: Bychkov
authors.forename: N V
authors.initials: NV
authors.lastname: Mindra
authors.forename: M B
authors.initials: MB
authors.lastname: Stenina
authors.forename: S V
authors.initials: SV
authors.lastname: Topchieva
authors.forename: E M
authors.initials: EM
authors.lastname: Treshchalina
authors.forename: L V
authors.initials: LV
authors.lastname: Chitiia
authors.forename: A M
authors.initials: AM
authors.lastname: Sdvizhkov
authors.forename: V I
authors.initials: VI
authors.lastname: Borisov
authors.forename: S N
authors.initials: SN
authors.lastname: Gurov
authors.forename: M L
authors.initials: ML
authors.lastname: Gershanovich
authors.forename: E V
authors.initials: EV
authors.lastname: Makhnova
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002208:Caproates; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007165:Immunosuppression Therapy; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D019891:Leukopoiesis / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D002208:Caproates; D007093:Imidazoles; C539419:pentanedioic acid imidazolyl ethanamide